کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3303553 1210317 2014 11 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Endoscopic submucosal dissection for gastric tube cancer after esophagectomy
ترجمه فارسی عنوان
انسداد ساب موکوسیال آندوسکوپی برای سرطان لوله گوارشی پس از مزوفاکتومی
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی بیماری‌های گوارشی
چکیده انگلیسی

BackgroundRecent improvements in the survival of patients after esophagectomy have led to an increasing occurrence of gastric tube cancer (GTC). Removal of the reconstructed gastric tube, however, can lead to high morbidity and mortality.ObjectiveTo assess the feasibility and effectiveness of endoscopic submucosal dissection (ESD) for GTC.DesignRetrospective study.SettingNational Cancer Center Hospital, Tokyo, Japan.PatientsWe investigated patients with GTC after esophagectomy undergoing ESD from 1998 to 2011.InterventionESD.Main Outcome MeasurementsPatient characteristics, endoscopic findings, technical results, histopathology including curability and Helicobacter pylori gastritis, and long-term outcomes.ResultsThere were 51 consecutive patients with 79 lesions including 38 lesions (48%) meeting the absolute indication, 31 (39%) satisfying the expanded indications, and 10 (13%) falling outside such indications. The median procedure time was 90 minutes. There were 73 en bloc resections (92%), 59 en bloc resections with tumor-free margins (R0 resections, 75%), and 51 curative resections (65%) based on the Japanese Gastric Cancer Association criteria. Fifty patients (98%) were assessed as H pylori gastritis positive. Adverse events included 3 perforations (3.8%) during ESD and 2 delayed perforations (2.5%) without any emergency surgery and 3 delayed bleeding (3.8%). Local recurrence was detected in 4 patients (7.8%), and metachronous GTCs were identified in 18 patients (35%). Five patients (10%) died of GTC including 3 metachronous lesions. The 5-year overall survival rate was 68.4%, and the disease-specific survival rate was 86.7% with 100% for curative and 72.7% for non-curative patients during a median follow-up period of 3.8 years (range, 0-12.1 years).LimitationSingle-center retrospective study.ConclusionsESD for GTC was feasible and effective for curative patients; however, long-term outcomes for non-curative patients were less satisfactory.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Gastrointestinal Endoscopy - Volume 79, Issue 2, February 2014, Pages 260–270
نویسندگان
, , , , , , , , , , , ,